Biomarker tests detect early Alzheimer’s pathology.

A periodontology trainee makes stem cell science inroads at Pitt

University of Pittsburgh researchers discovered that lysosomal dysfunction, driven by a genetic variant affecting the NCOA7 protein, contributes to inflammation and increased mortality risk in pulmonary arterial hypertension—revealing potential biomarkers and therapeutic targets.

Pitt BioForge is poised to help manufacture precision biomedical medicine.

Pitt’s tradition of innovation is channeled toward engineering the future of life sciences, with a focus on translating groundbreaking discoveries into viable products that have the greatest possible impact on patients.

Targeting tumors through nanomedicine is leading to big results.